Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome

Blood

Volumn 92, Issue 7, 1998, Pages 2421-2434

  Seyama, Kuniaki ^b   Nonoyama, Shigeaki ^b   Gangsaas, Ingvild ^b   Hollenbaugh, Diane ^b   Pabst, Henry F ^b   Aruffo, Alejandro ^b   Ochs, Hans D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 39; IMMUNOGLOBULIN M;

ADULT; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; HYPERIMMUNOGLOBULINEMIA; IMMUNE DEFICIENCY; INFANT; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; X CHROMOSOME LINKAGE;

EID: 0032190068     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.7.2421     Document Type: Article

References (60)

1. Notarangelo, LD, Duse M, Ugazio AG: Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 3:101, 1992
2. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EAM, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarström L, Abrabamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD: Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131:44, 1997
3. Hayward AR, Levy L, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M, Weinberg A: Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 158:977, 1997
4. Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch AS, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11:4313, 1992
5. Graf D, Korthauer U, Mages HW, Senger G, Kroczek RA: Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol 22:3191, 1992
6. Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC: Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 176:1543, 1992
7. Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD: The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291, 1993
8. Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA: Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539, 1993
9. Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen FS, Chatila T, Fu SM, Stamenkovic I, Geha RS: 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 90:2170, 1993
10. DiSanto JP, Bonnefoy JY, Gauchat JF, Fischer A, Basile GDS: CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361:541, 1993
11. Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, Fanslow WC, Belmont J, Spriggs MK: CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990, 1993
12. Villa A, Notarangelo LD, DiSanto JP, Macchi PP, Strina D, Frattini A, Lucchini F, Patrosso CM, Giliani S, Mantuano E, Agosti S, Nocera G, Kroczek RA, Fischer A, Ugazio AG, Basile GDS, Vezzoni P: Organization of the human CD40L gene: Implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc Natl Acad Sci USA 91:2110, 1994
13. Seyama K, Kira S, Ishidoh K, Souma S, Miyakawa T, Kominami E: Genomic structure and PCR-SSCP analysis of the human CD40 ligand gene: Its application to prenatal screening for X-linked hyper-IgM syndrome. Hum Genet 97:180, 1996
14. Karpusas M, Hsu YM, Wang JH, Thompson J, Lederman S, Chess L, Thomas D: 2 A crystal structure of an extracellular fragment of human CD40 ligand. Structure 3:1031, 1995
15. Bajorath J, Seyama K, Nonoyama S, Ochs HD, Aruffo A: Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome. Protein Sci 5:531, 1996
16. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ: The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 15:406, 1994
17. Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK: CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178:669, 1993
18. Wagner JDH, Stout RD, Suttles J: Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur J Immunol 24:3148, 1994
19. Kiener PA, Moran DP, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D: Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155:4917, 1995
20. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263, 1994
21. Hollenbaugh D, Mischel PN, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A: Expression of functional CD40 by vascular endothelial cells. J Exp Med 182:33, 1995
22. Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, Chess L: Functional interactions of T cells with endothelial cells: The role of CD40L-CD40-mediated signals. J Exp Med 182:1857, 1995
23. Notarangelo LD, Peitsch MC: CD401base: A database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 17:511, 1996
24. Pabst HF, Chung GSH, Segal D, Dolen J: Mild combined immunodeficiency in identical twins. J Pediatr 89:425, 1976
25. Nonoyama S, Shimadzu M, Toru H, Seyama K, Nunoi H, Neubauer M, Yata J, Ochs HD: Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum Genet 99:624, 1997
26. Hollenbaugh D, Wu LH, Ochs HD, Nonoyama S, Grosmaire LS, Ledbetter JA, Noelle RJ, Hill H, Aruffo A: The random inactivation of the X chromosome carrying the detective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1. J Clin Invest 94:616, 1994
27. Iseki M, Anzo M, Yamashita N, Matsuo N: Hyper-IgM immunodeficiency with disseminated cryptococcosis. Acta Paediatr 83:780, 1994
28. Saiki O, Tanaka T, Wada Y, Uda H, Inoue A, Katada Y, Izeki M, Iwata M, Nunoi H, Matsuda I, Kinoshita N, Kishimoto T: Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM. J Clin Invest 95:510, 1995
29. Lin Q, Rohrer J, Allen RC, Larch'e M, Greene JM, Shigeoka AO, Gatti RA, Derauf DC, Belmont JW, Conley ME: A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome. J Clin Invest 97:196, 1996
30. Nutman TB: Generation and maintenance of T cell lines and clones, in Coligan JE, Kruisbeek AM, Margulies DH, Shevach EH, Strober W (eds): Current Protocols in Immunology, vol 2. Somerset, NJ, Wiley, Current Protocols, 1992, p7.19.1
31. Nonoyama S, Penix LA, Edwards CP, Lewis DB, Ito S, Aruffo A, Wilson CB, Ochs HD: Diminished expression of CD40 ligand by activated neonatal T cells. J Clin Invest 95:66, 1995
32. Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR: Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 12:7035, 1984
33. Elsen PVD, Shepley BA, Borst J, Coligan JE, Markham AF, Orkin S, Terhorst C: Isolation of cDNA clones encoding the 20K T3 glycoprotein of human T-cell receptor complex. Nature 312:413, 1984
34. Johnston RF, Pickett SC, Barker DL: Autoradiography using storage phosphor technology. Electrophoresis 11:355, 1990
35. Ochs HD, Davis SD, Wedgwood RJ: Immunologic responses to bacteriophage φX174 in immunodeficiency diseases. J Clin Invest 50:2559, 1971
36. Pyun KH, Ochs HD, Wedgwood RJ, Yang X, Heller SR, Reimer CB: Human antibody responses to bacteriophage φX 174: Sequential induction of IgM and IgG subclass antibody. Clin Immunol Immunopathol 51:252, 1989
37. Farrington M, Grosmaire LS, Nonoyama S, Fischer SH, Hollenbaugh D, Ledbetter JA, Noelle RJ, Aruffo A, Ochs HD: CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA 91:1099, 1994
38. Villa A, Strina D, Macchi P, Patrosso MC, Vezzoni P, Tovo PA, Giliani S, Ugazio AG, Notarangelo LD: C to T mutation causing premature termination of CD40 ligand at amino acid 221 in a patient affected by hyper IgM syndrome. Hum Mutat 3:73, 1994
39. Macchi P, Villa A, Strina D, Sacco MG, Morali F, Brugnoni D, Giliani S, Mantuano E, Fasth A, Andersson B, Zergers BJM, Cavagni G, Reznick I, Levy J, Zan-Bar I, Porat Y, Airo P, Plebani A, Vezzoni P, Notarangelo LD: Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry. Am J Hum Genet 56:898, 1995
40. Katz F, Hinshelwood S, Rutland P, Jones A, Kinnon C, Morgan G: Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome. Hum Mutat 8:223, 1996
41. Jackson IJ: A reappraisal of non-consensus mRNA splice sites. Nucleic Acids Res 19:3795, 1991
42. Aebi M, Hornig H, Weissmann C: 5′ Cleavage site in eukaryotic pre-mRNA splicing is determined by the overall 5′ splice region, not by the conserved 5′ GU. Cell 50:237, 1987
43. Orita M, Suzuki Y, Sekiya T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874, 1989
44. Sarkar G, Yoon HS, Sommer, SS: Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutations. Genomics 13:441, 1992
45. Bajorath J, Marken JS, Chalupny NJ, Spoon TL, Siadak AW, Gordon M, Noelle RJ, Hollenbaugh D, Aruffo A: Analysis of gp39/ CD40 interactions using molecular models and site-directed mutagenesis. Biochemistry 34:9884, 1995
46. Ameratunga, R, McKee J, French J, Prestidge R, Fanslow W, Marbrook J: Molecular pathology of the X-linked hyper-immunoglobulin M syndrome: Detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligand. Clin Diagn Lab Immunol 3:722, 1996
47. Stagno S, Pifer LL, Hughes WT, Brasfield DM, Tiller RE: Pneumocystis carinii pneumonitis in young immunocompetent infants. Pediatrics 66:56, 1980
48. Callard RE, Smith SH, Herbert J, Morgan G, Padayachee M, Lederman S, Chess L, Kroczek RA, Fanslow WC, Armitage RJ: CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM): Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers. J Immunol 153:3295, 1994
49. Grewal IS, Flavell, RA: A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol Today 17:410, 1996
50. Yang Y, Wilson JM: CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40. Science 273:1862, 1996
51. Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, Janeway CAJ, Flavell RA: Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273:1864, 1996
52. Durandy A, Schiff C, Bonnefoy JY, Forveille M, Rousset F, Mazzei G, Milili M, Fischer A: Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome. Eur J Immunol 23:2294, 1993
53. Nonoyama S, Hollenbaugh D, Aruffo A, Ledbetter JA, Ochs HD: B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med 178:1097, 1993
54. Hess S, Engelmann H: A novel function of CD40: Induction of cell death in transformed cells. J Exp Med 183:159, 1996
55. Stout RD, Suttles J: The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 17:487, 1996
56. Tian L, Noelle RJ, Lawrence DA: Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur J Immunol 25:306, 1995
57. Stout RD, Suttles J, Xu J, Grewal IS, Flavell RA: Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 156:8, 1996
58. Soong L, Xu JC, Grewal IS, Kima P, Sun J, Longley BJJ, Ruddle NH, McMahon PD, Flavell RA: Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263, 1996
59. Morosawa H, Yamazaki M, Sugita K, Saitoh H, Komiyama A, Akabane T: Intrinsic neutrophil defects in a child with impaired neutrophil chemotaxis and immunodeficiency. Am J Hematol 8:403, 1980
60. Hasle H, Kerndrup G, Jacobsen BB, Heegaard ED, Hornsleth A, Lillevang ST: Chronic parvovirus infection mimicking myelodysplastic syndrome in a child with subclinical immunodeficiency. Am J Pediatr Hematol Oncol 16:329, 1994